Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy.
Saved in:
| Title: | Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy. |
|---|---|
| Authors: | Khan AA; Rush University Medical Center, Chicago, IL, USA., Gurnani PK; Rush University Medical Center, Chicago, IL, USA., Peksa GD; Rush University Medical Center, Chicago, IL, USA., Whittier WL; Rush University Medical Center, Chicago, IL, USA., DeMott JM; Rush University Medical Center, Chicago, IL, USA. |
| Source: | The Annals of pharmacotherapy [Ann Pharmacother] 2021 Mar; Vol. 55 (3), pp. 277-285. Date of Electronic Publication: 2020 Sep 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: United States NLM ID: 9203131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-6270 (Electronic) Linking ISSN: 10600280 NLM ISO Abbreviation: Ann Pharmacother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32885992 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Khan+AA%22">Khan AA</searchLink>; Rush University Medical Center, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Gurnani+PK%22">Gurnani PK</searchLink>; Rush University Medical Center, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Peksa+GD%22">Peksa GD</searchLink>; Rush University Medical Center, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Whittier+WL%22">Whittier WL</searchLink>; Rush University Medical Center, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22DeMott+JM%22">DeMott JM</searchLink>; Rush University Medical Center, Chicago, IL, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229203131%22">The Annals of pharmacotherapy</searchLink> [Ann Pharmacother] 2021 Mar; Vol. 55 (3), pp. 277-285. <i>Date of Electronic Publication: </i>2020 Sep 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203131 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1542-6270 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210600280%22">10600280 </searchLink><i>NLM ISO Abbreviation: </i>Ann Pharmacother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32885992 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/1060028020957048 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 277 Titles: – TitleFull: Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Khan AA – PersonEntity: Name: NameFull: Gurnani PK – PersonEntity: Name: NameFull: Peksa GD – PersonEntity: Name: NameFull: Whittier WL – PersonEntity: Name: NameFull: DeMott JM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2021 Mar Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1542-6270 Numbering: – Type: volume Value: 55 – Type: issue Value: 3 Titles: – TitleFull: The Annals of pharmacotherapy Type: main |
| ResultId | 1 |
